ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 05/08/2024 at 08:30, 2 years 2 months ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024

Abivax Obefazimod Rectocolite Hémorragique Cancer Du Côlon Digestive Disease Week 2024
PRESS RELEASE

published on 05/08/2024 at 08:30, 2 years 2 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 2 years 2 months ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF

published on 05/07/2024 at 22:05, 2 years 2 months ago

Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale

Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE

published on 05/07/2024 at 22:01, 2 years 2 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires

Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE

published on 05/07/2024 at 22:00, 2 years 2 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 2 years 2 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 2 years 2 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF

published on 04/30/2024 at 18:05, 2 years 3 months ago

ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024

Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF

published on 04/30/2024 at 18:05, 2 years 3 months ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information

Published on 08/07/2026 at 00:45, 55 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 2 hours 25 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 3 hours 25 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 3 hours 35 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 3 hours 40 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE

View all ACCESSWIRE

Published on 08/06/2026 at 22:50, 2 hours 50 minutes ago

Amrize Reports Second Quarter 2026 Results
Published on 08/06/2026 at 22:15, 3 hours 25 minutes ago

BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 3 hours 54 minutes ago

FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 6 hours 34 minutes ago

Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 7 hours 15 minutes ago

EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026

View all EQS

Published on 08/06/2026 at 18:26, 7 hours 14 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 7 hours 14 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 7 hours 54 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 7 hours 55 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 7 hours 55 minutes ago

Declaration of voting rights at the end of July 2026

View all LES ECHOS COMFI WIRE

News